Seroepidemiology of Human Polyomaviruses in a US Population.
about
In Vitro and In Vivo Models for the Study of Human Polyomavirus InfectionSerum biomarkers of polyomavirus infection and risk of lung cancer in never smokersUse of natalizumab in multiple sclerosis: current perspectives.Preclinical evaluation of NF-κB-triggered dendritic cells expressing the viral oncogenic driver of Merkel cell carcinoma for therapeutic vaccination.Genome editing and the next generation of antiviral therapy.Human polyomavirus and human papillomavirus prevalence and viral load in non-malignant tonsillar tissue and tonsillar carcinoma.Prospective Study of Human Polyomaviruses and Risk of Cutaneous Squamous Cell Carcinoma in the United StatesHuman polyomaviruses and incidence of cutaneous squamous cell carcinoma in the New Hampshire skin cancer studyImperfect Symmetry of Sp1 and Core Promoter Sequences Regulates Early and Late Virus Gene Expression of the Bidirectional BK Polyomavirus Noncoding Control Region.Specific and quantitative detection of Human polyomaviruses BKPyV and JCPyV in the healthy Pakistani populationJC virus infection is acquired very early in life: evidence from a longitudinal serological study.BK viremia surveillance and outcomes in simultaneous pancreas-kidney transplant recipients.Quantitative detection of human Malawi polyomavirus in nasopharyngeal aspirates, sera, and feces in Beijing, China, using real-time TaqMan-based PCR.Merkel cell polyomavirus and Merkel cell carcinoma.Complete genome sequence of a KI polyomavirus isolated from an otherwise healthy child with severe lower respiratory tract infection.Primary Polyomavirus Infection, Not Reactivation, as the Cause of Trichodysplasia Spinulosa in Immunocompromised Patients.Complete Genome Sequence of a Novel Human WU Polyomavirus Isolate Associated with Acute Respiratory Infection.Survey of KI, WU, MW, and STL Polyomavirus in Cancerous and Non-Cancerous Lung Tissues.A Role of Sp1 Binding Motifs in Basal and Large T-Antigen-Induced Promoter Activities of Human Polyomavirus HPyV9 and Its Variant UF-1.Infectious Entry and Neutralization of Pathogenic JC Polyomaviruses.Inhibition of Retrograde Transport Limits Polyomavirus Infection In Vivo.Development and evaluation of a broad bead-based multiplex immunoassay to measure IgG seroreactivity against human polyomaviruses.Novel Human Polyomavirus non-coding control regions differ in bi-directional gene expression according to host cell, large T-antigen expression, and clinically occurring rearrangements.Antibody response to polyomavirus primary infection: high seroprevalence of Merkel cell polyomavirus and lymphoid tissue involvement.Prevalence and Genetic Variability of Human Polyomaviruses 6 and 7 in Healthy Skin Among Asymptomatic Individuals.Age-specific seroprevalence of human polyomavirus 12 and Saint Louis and New Jersey polyomaviruses.The Human Polyomavirus Middle and Alternative T-Antigens; Thoughts on Roles and Relevance to Cancer.
P2860
Q28074684-37048AE4-03B9-4719-AA01-AC5C03D59B0BQ28394577-48F0967E-6616-41E6-BF9E-7C30A7DBE997Q31114633-D623CE11-E53C-40F0-9B5D-D5C1951D3C97Q33887689-CD51565D-7049-4918-9C37-8DFCED313E3CQ34529971-6AE921FE-735B-4EF8-896B-4EFA76F0DF02Q34544410-CD061781-49CD-49B7-A5D0-8CBF0EA84610Q36943859-7E3FD782-6483-4489-A769-276B90D47A29Q37045585-B1A90DD4-FA2F-4690-BB23-34D3B42DDCF7Q38736149-DE93EB95-26E4-4DB2-8364-4268C2E1D6E6Q38822430-A130A661-B04B-49F9-A1B4-2907CC2C9524Q38830062-92C65C94-71C0-40E5-98DE-5C61D51D005FQ39309624-BBAB9327-E489-4EF2-9AA2-64D1C56E4A65Q40043433-6FF8663D-FFB4-4C17-8B77-ABAE05312C12Q40046580-2D53A0A1-903E-4E3A-AE59-65D647425265Q40516329-EF900EEE-3443-4001-BCAA-B4FD943CEE67Q40557131-ADA3FBB1-5224-4525-9485-7CDB555E1CAFQ40685211-E884C324-D18E-4023-A04A-52D350E422BBQ41927286-005B00B5-1870-498E-AA1A-DBBC50D74894Q47125399-F3481D40-A823-4B64-8338-5F5826455DEEQ47147327-4D1198D9-D741-4C8A-97D7-D1737839B7DCQ47159198-739C7C0B-0719-418F-990F-09A619659804Q47228508-FEDD2BB4-110D-4D45-900A-FB3C4DA9E154Q47552262-FEDC6841-52CD-4E07-AEDD-E73CCA41DAE5Q47554034-D6B9A845-6034-47D5-B04C-AC1CC8128A27Q47574514-A3B118D7-2FDC-4A4A-BAF9-B269392862F7Q51735749-694D27F2-9314-4A84-88AA-46B74241A4FAQ52641622-06F0A282-A759-4C11-8168-5AF5684D8E4A
P2860
Seroepidemiology of Human Polyomaviruses in a US Population.
description
2015 nî lūn-bûn
@nan
2015 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Seroepidemiology of Human Polyomaviruses in a US Population.
@ast
Seroepidemiology of Human Polyomaviruses in a US Population.
@en
Seroepidemiology of Human Polyomaviruses in a US Population.
@nl
type
label
Seroepidemiology of Human Polyomaviruses in a US Population.
@ast
Seroepidemiology of Human Polyomaviruses in a US Population.
@en
Seroepidemiology of Human Polyomaviruses in a US Population.
@nl
prefLabel
Seroepidemiology of Human Polyomaviruses in a US Population.
@ast
Seroepidemiology of Human Polyomaviruses in a US Population.
@en
Seroepidemiology of Human Polyomaviruses in a US Population.
@nl
P2093
P2860
P50
P356
P1476
Seroepidemiology of Human Polyomaviruses in a US Population.
@en
P2093
Anala Gossai
Angelika Michel
Brock C Christensen
Carmen J Marsit
Karl T Kelsey
Margaret R Karagas
Shohreh F Farzan
P2860
P356
10.1093/AJE/KWV155
P407
P577
2015-12-13T00:00:00Z